Status:
UNKNOWN
French Adult Primary Immune Thrombocytopenia
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Thrombocytopenia
Eligibility:
All Genders
18+ years
Brief Summary
Primary immune thrombocytopenia (ITP) is rare. First-line treatment is corticotherapy. Then, several second-line treatments (SLT) are available: splenectomy, off-label rituximab and thrombopoietin-rec...
Eligibility Criteria
Inclusion
- Incident case of immune thrombocytopenia or control patient
Exclusion
- Patient not registered in the database between 2009 and 2012
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03429660
Start Date
October 1 2013
End Date
May 1 2023
Last Update
October 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Toulouse
Toulouse, France, 31059